The stock of Rewalk Robotics Ltd (NASDAQ:RWLK) hit a new 52-week low and has $2.29 target or 12.00% below today’s $2.60 share price. The 6 months bearish chart indicates high risk for the $41.68 million company. The 1-year low was reported on Nov, 10 by Barchart.com. If the $2.29 price target is reached, the company will be worth $5.00 million less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock. The stock decreased 1.89% or $0.05 on November 10, hitting $2.6. About 143,515 shares traded hands. Rewalk Robotics Ltd (NASDAQ:RWLK) has declined 70.59% since April 8, 2016 and is downtrending. It has underperformed by 76.24% the S&P500.
Rewalk Robotics Ltd (NASDAQ:RWLK) Ratings Coverage
Out of 3 analysts covering Rewalk Robotics (NASDAQ:RWLK), 1 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 33% are positive. Rewalk Robotics has been the topic of 7 analyst reports since August 10, 2015 according to StockzIntelligence Inc. The rating was upgraded by Zacks to “Hold” on Tuesday, September 8. Zacks downgraded Rewalk Robotics Ltd (NASDAQ:RWLK) on Friday, August 14 to “Hold” rating. The stock of Rewalk Robotics Ltd (NASDAQ:RWLK) earned “Overweight” rating by Piper Jaffray on Friday, July 15. As per Monday, August 10, the company rating was maintained by Jefferies. The stock of Rewalk Robotics Ltd (NASDAQ:RWLK) has “Sell” rating given on Tuesday, August 25 by Zacks.
According to Zacks Investment Research, “ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with spinal cord injury. The Company’s exoskeletons allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk once again. It offers ReWalk Personal for everyday use to individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy to individuals with lower limb disabilities in the clinical rehabilitation environment. ReWalk Robotics Ltd. is headquartered in Yokneam Ilit, Israel.”
More news for Rewalk Robotics Ltd (NASDAQ:RWLK) were recently published by: 247Wallst.com, which released: “ReWalk Robotics Slides on Secondary Offering” on October 27, 2016. Prnewswire.com‘s article titled: “ReWalk Announces Launch of 522 Post-Market Study with Stanford University …” and published on August 02, 2016 is yet another important article.
RWLK Company Profile
ReWalk Robotics Ltd., incorporated on June 20, 2001, is a medical device company. The Firm is engaged in designing, developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk. It offers ReWalk, an exoskeleton that uses its tilt-sensor technology, and an on-board computer and motion sensors to drive motorized legs that power movement. ReWalk creates focus on people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, who have the use of their upper bodies and arms. It offers various products, which include ReWalk Personal and ReWalk Rehabilitation.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.